TTALO — Terveystalo Oyj Cashflow Statement
0.000.00%
- €1.51bn
- €2.01bn
- €1.34bn
- 95
- 54
- 100
- 98
Annual cashflow statement for Terveystalo Oyj, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 56.6 | 101 | 30.9 | -38.9 | 89.6 |
Depreciation | |||||
Non-Cash Items | 10.2 | 11.1 | -1 | 15.2 | 24.8 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -14.3 | -8.3 | -23.9 | -12.1 | 2.9 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Payable / Accrued Expenses | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 144 | 195 | 141 | 158 | 224 |
Capital Expenditures | -33.1 | -43.1 | -59.2 | -41 | -39.6 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -2.9 | -64.9 | -34.7 | -3.2 | -7.8 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -36 | -108 | -93.9 | -44.2 | -47.4 |
Financing Cash Flow Items | -15.5 | -27.9 | -13.7 | -24.2 | -27.1 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -71.2 | -126 | -44.6 | -116 | -149 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 36.5 | -39 | 2.1 | -2.5 | 27.4 |